Generic Drugs Market

“Generic Drugs Market - Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2023-2028” provides a deep and thorough evaluation of the global generic drugs market. Generic drugs refer to pharmaceutical medicines that contain the same ingredient as an existing branded drug. They are identical in terms of dosage, administration, quality and characteristics to the original drug. Generic drugs are commonly available in liquid syrups, tablets, capsules, inhalers, drops and injections. As compared to the branded drugs, they are easy to obtain and assist the patients in staying on course due to their cost-effectiveness.

The global generic drugs market is primarily being driven by the increasing prevalence of chronic diseases, such as asthma and diabetes, along with the rising geriatric population. Furthermore, various technological advancements, such as the advent of 3D printing technologies, which enable the drug manufacturers to customize the size, shape and texture of drugs for enhanced efficacy and cost-effectiveness, are contributing to the market growth.

Beginning with a global overview, the report explores the dynamics that have a strong influence on the generic drugs market and can also impact its future growth. Taking 2022 as the base year, the report covers the historical market scenario from 2017-2022 and provides forecasts till 2028. This includes the study of value and volume trends and pricing history. Growth-inducing factors, market restraints and recent developments have also been analysed in the report in order to provide deeper knowledge about the industry. On a regional basis, the report examines the generic drugs market in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. For each of these regions, the report studies the generic drugs market in detail for the latest trends, outlook and opportunities.

The report analyses the competitive structure of the generic drugs Industry and provides the profiles of major players operating in the market. The price margins for the products, along with the various success and risk factors for manufacturers, have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the generic drugs Industry along the parameters of Porter’s Five Forces model. This model examines the degree of competition in the generic drugs Industry by analysing the threat posed by new entrants and substitutes and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report, which highlights the strengths, weaknesses, opportunities and threats pertaining to the generic drugs Industry. Furthermore, the value chain analysis of the generic drugs Industry has also been covered in the report. This comprises all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution. 

Key Segments and Highlights of the Global Generic Drugs Market 

• Historical and current scenario
• Trends and developments
• Impact of COVID-19
• Market forecast
• Price analysis and forecast
• Porter’s five forces analysis
• SWOT analysis
• Value chain analysis
• Market Breakup by Type
• Market Breakup by End-Use
• Market Breakup by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

• Key players         

The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the generic drugs Industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.